FutureLab NMN 500 mg Powder is a TGA-listed complementary medicine formulated to support energy production, physical endurance and general health and wellbeing in ageing individuals.

Developed by Melrose Laboratories, Australia's longevity leader, it delivers a clinically relevant 500 mg dose of Nicotinamide Mononucleotide (NMN) per serving, supporting NAD-dependent cellular pathways that decline with age.

• Maintain/support energy production

• Maintain/support body metabolism

• Support physical endurance in ageing individuals

• Support general health and wellbeing

• Support general health in ageing individuals

• Support nervous system health and function

• Enhance nutrient levels in the body

A premium powdered formula designed to support cellular energy and wellbeing.

As a direct precursor to NAD+ (nicotinamide adenine dinucleotide), NMN helps drive cellular energy production. NAD+ is a fundamental coenzyme found in every cell,

central to energy metabolism and overall wellbeing.

Each serving supplies 500 mg of NMN in a pure unflavoured, easy-to-mix powder which integrates effortlessly into your daily routine

• Nicotinamide Mononucleotide
• (NMN) 500 mg
• Glycine 2.4 g

Format: Powder

Serve: 3 g scoop

Servings: 30 serves/jar

Frequency: Once daily

Vegan, gluten free & dairy free.

Store below 25°C away from direct sunlight.

Warnings:

Do not use if pregnant or likely to become pregnant, or during lactation.

The maximum recommended daily dose of the medicine must not exceed 500 mg of nicotinamide mononucleotide.

The recommended duration of use for a medicine containing nicotinamide mononucleotide must be 12 weeks or less.

Nutrients can only be of assistance if dietary intake is inadequate.

Do not use if tamper evident seals are broken or missing.